Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(20%)
Results Posted
25%(1 trials)

Phase Distribution

Ph not_applicable
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(4)

Detailed Status

Completed4
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

recruiting120%
completed480%

Recent Activity

1 active trials
Showing 5 of 5
recruitingnot_applicable

Cognitive Behavioral Therapy for Fear of Cancer Recurrence in Women With BRCA1/2 Gene

NCT06817694
completednot_applicable

Evaluation of a New CBT for People With Alzheimer's Disease and Their Caregivers

NCT03656159
completednot_applicable

New Haven MOMS Partnership

NCT01665872
completednot_applicable

Preventing Anxiety Disorders in Urban Youth

NCT00073619
completednot_applicable

Cognitive-behavioral (CBT) in ESRD Patients With Depression

NCT02011139

Clinical Trials (5)

Showing 5 of 5 trials
NCT06817694Not Applicable

Cognitive Behavioral Therapy for Fear of Cancer Recurrence in Women With BRCA1/2 Gene

Recruiting
NCT03656159Not Applicable

Evaluation of a New CBT for People With Alzheimer's Disease and Their Caregivers

Completed
NCT01665872Not Applicable

New Haven MOMS Partnership

Completed
NCT00073619Not Applicable

Preventing Anxiety Disorders in Urban Youth

Completed
NCT02011139Not Applicable

Cognitive-behavioral (CBT) in ESRD Patients With Depression

Completed

All 5 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
5